Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod Region

The objective: to analyze the results of preventive treatment (PT) of tuberculosis in HIV infected patients in Nizhny Novgorod Region.Subjects and methods: in 2015-2017, preventive treatment of tuberculosis was prescribed to 1,374 people living with HIV (PLHIV), registered in TB dispensaries. Before...

Full description

Saved in:
Bibliographic Details
Main Authors: G. F. Rusanovskaya, S. V. Minaeva, N. N. Sidorova, V. A. Balaganin, S. A. Аpoyan
Format: Article
Language:Russian
Published: New Terra Publishing House 2019-10-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/1333
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850187877945704448
author G. F. Rusanovskaya
S. V. Minaeva
N. N. Sidorova
V. A. Balaganin
S. A. Аpoyan
author_facet G. F. Rusanovskaya
S. V. Minaeva
N. N. Sidorova
V. A. Balaganin
S. A. Аpoyan
author_sort G. F. Rusanovskaya
collection DOAJ
description The objective: to analyze the results of preventive treatment (PT) of tuberculosis in HIV infected patients in Nizhny Novgorod Region.Subjects and methods: in 2015-2017, preventive treatment of tuberculosis was prescribed to 1,374 people living with HIV (PLHIV), registered in TB dispensaries. Before the prescription of preventive treatment, patients underwent a comprehensive examination to exclude active tuberculosis, including digital chest X-ray. For immunodiagnostics of latent tuberculosis infection, an intradermal Mantoux test with 2 TU of purified tuberculin in standard dilution was used. The immune status was assessed based on CD4+ count. The effectiveness of antiretroviral therapy (ARVT) was assessed by the concentration of HIV RNA in the blood; when achieving complete viral suppression (less than 58 copies of HIV RNA in μl), ARVT was found to be effective. Preventive treatment included isoniazid at a dose of 5 mg per kg of patient body weight in combination with vitamin B6 (pyridoxine hydrochloride) at the dose of 15-25 mg/day (tablet) for 6 months.Results. The efficacy of preventive treatment was assessed by 2-year survival free of active tuberculosis in those who started preventive treatment (including those who did not complete it). There were organizational problems while administering preventive treatment of tuberculosis people living with HIV: low adherence to treatment, difficulties in monitoring drug in-take and adverse events monitoring. Only 601/1,374 – 43.7% of people completed the entire 6-month course. Tuberculosis developed in 10 (0.7 ± 2.7%) of 1,374 PLHIV who started preventive treatment, of which 9/10 at that time had CD4+ count below 350 cells/μl, and 8/10 patients refused or interrupted ART. Among PLHIV who completed the 6-month course of preventive treatment, 1 of 601 (0.17%) developed tuberculosis, while among those who interrupted – 9/773 (1.16%) (χ2 = 4.66; p < 0.05), which made 170 and 1,160 per 100,000 decreed population, respectively. The presented results allow concluding that preventive treatment of tuberculosis is advisable for PLHIV.
format Article
id doaj-art-5e9ce123777842fca46f89cbbfd0e874
institution OA Journals
issn 2075-1230
2542-1506
language Russian
publishDate 2019-10-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-5e9ce123777842fca46f89cbbfd0e8742025-08-20T02:16:01ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062019-10-01979283210.21292/2075-1230-2019-97-9-28-321333Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod RegionG. F. Rusanovskaya0S. V. Minaeva1N. N. Sidorova2V. A. Balaganin3S. A. Аpoyan4Nizhny Novgorod Center for AIDS and Infectious Diseases Prevention and Control; Privolzhskiy Research Medical UniversityNizhny Novgorod Center for AIDS and Infectious Diseases Prevention and Control; Privolzhskiy Research Medical UniversityNizhny Novgorod Center for AIDS and Infectious Diseases Prevention and Control; Privolzhskiy Research Medical UniversityNizhny Novgorod Center for AIDS and Infectious Diseases Prevention and ControlNizhny Novgorod Center for AIDS and Infectious Diseases Prevention and ControlThe objective: to analyze the results of preventive treatment (PT) of tuberculosis in HIV infected patients in Nizhny Novgorod Region.Subjects and methods: in 2015-2017, preventive treatment of tuberculosis was prescribed to 1,374 people living with HIV (PLHIV), registered in TB dispensaries. Before the prescription of preventive treatment, patients underwent a comprehensive examination to exclude active tuberculosis, including digital chest X-ray. For immunodiagnostics of latent tuberculosis infection, an intradermal Mantoux test with 2 TU of purified tuberculin in standard dilution was used. The immune status was assessed based on CD4+ count. The effectiveness of antiretroviral therapy (ARVT) was assessed by the concentration of HIV RNA in the blood; when achieving complete viral suppression (less than 58 copies of HIV RNA in μl), ARVT was found to be effective. Preventive treatment included isoniazid at a dose of 5 mg per kg of patient body weight in combination with vitamin B6 (pyridoxine hydrochloride) at the dose of 15-25 mg/day (tablet) for 6 months.Results. The efficacy of preventive treatment was assessed by 2-year survival free of active tuberculosis in those who started preventive treatment (including those who did not complete it). There were organizational problems while administering preventive treatment of tuberculosis people living with HIV: low adherence to treatment, difficulties in monitoring drug in-take and adverse events monitoring. Only 601/1,374 – 43.7% of people completed the entire 6-month course. Tuberculosis developed in 10 (0.7 ± 2.7%) of 1,374 PLHIV who started preventive treatment, of which 9/10 at that time had CD4+ count below 350 cells/μl, and 8/10 patients refused or interrupted ART. Among PLHIV who completed the 6-month course of preventive treatment, 1 of 601 (0.17%) developed tuberculosis, while among those who interrupted – 9/773 (1.16%) (χ2 = 4.66; p < 0.05), which made 170 and 1,160 per 100,000 decreed population, respectively. The presented results allow concluding that preventive treatment of tuberculosis is advisable for PLHIV.https://www.tibl-journal.com/jour/article/view/1333tuberculosishiv infectiontb/hiv co-infectionpreventive chemotherapy
spellingShingle G. F. Rusanovskaya
S. V. Minaeva
N. N. Sidorova
V. A. Balaganin
S. A. Аpoyan
Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod Region
Туберкулез и болезни лёгких
tuberculosis
hiv infection
tb/hiv co-infection
preventive chemotherapy
title Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod Region
title_full Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod Region
title_fullStr Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod Region
title_full_unstemmed Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod Region
title_short Results of preventive treatment of tuberculosis in HIV infected patients in Nizhny Novgorod Region
title_sort results of preventive treatment of tuberculosis in hiv infected patients in nizhny novgorod region
topic tuberculosis
hiv infection
tb/hiv co-infection
preventive chemotherapy
url https://www.tibl-journal.com/jour/article/view/1333
work_keys_str_mv AT gfrusanovskaya resultsofpreventivetreatmentoftuberculosisinhivinfectedpatientsinnizhnynovgorodregion
AT svminaeva resultsofpreventivetreatmentoftuberculosisinhivinfectedpatientsinnizhnynovgorodregion
AT nnsidorova resultsofpreventivetreatmentoftuberculosisinhivinfectedpatientsinnizhnynovgorodregion
AT vabalaganin resultsofpreventivetreatmentoftuberculosisinhivinfectedpatientsinnizhnynovgorodregion
AT saapoyan resultsofpreventivetreatmentoftuberculosisinhivinfectedpatientsinnizhnynovgorodregion